Improving cervical cancer screening for Somali immigrant women using self-sampling methods.
Reducing cervical cancer screening disparities in Somali immigrant women through a primary care based HPV self-sampling intervention
This study is looking to help Somali immigrant women in the U.S. get more cervical cancer screenings by offering a simple and respectful way to test for HPV during their regular doctor visits, making it easier for them to take care of their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11098741 on NIH RePORTER |
What this research studies
This research aims to address the low cervical cancer screening rates among Somali immigrant women in the U.S. by implementing a primary care-based HPV self-sampling intervention. The study recognizes cultural and religious barriers that contribute to this disparity and seeks to provide a more acceptable screening method that respects these concerns. By integrating HPV self-sampling into routine primary care visits, the research will evaluate its effectiveness and feasibility in increasing screening rates among this population. The approach is designed to empower women and healthcare providers to overcome existing barriers to cervical cancer screening.
Who could benefit from this research
Good fit: Ideal candidates for this research are Somali immigrant women who have historically low rates of cervical cancer screening.
Not a fit: Patients who are not Somali immigrant women or those who are already regularly screened for cervical cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase cervical cancer screening rates among Somali immigrant women, leading to earlier detection and better health outcomes.
How similar studies have performed: Previous research has shown promising results with HPV self-sampling in other populations, indicating potential for success in this novel application.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Pratt, Rebekah J. — University of Minnesota
- Study coordinator: Pratt, Rebekah J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.